Short chains of amino acids extracted from chicken egg yolk protected human nerve-like cells from oxidative damage in laboratory tests, according to work by Hyun-Dong Paik and colleagues at Konkuk University, published July 1, 2026 in Food Science of Animal Products. The team tested phosvitin phosphopeptides on SH-SY-5Y neuroblastoma cells and found that one preparation in particular cut levels of reactive oxygen species.
The peptides came from egg yolk that had been treated with high-temperature, mild-pressure processing and then hydrolyzed, a step that breaks large molecules into smaller fragments cells can take up more readily. The researchers compared several enzymes used for that breakdown - trypsin, the commercial preparation Multifect 14L, a combination of the two, and treated yolk material with no enzyme at all. The combined trypsin and Multifect 14L treatment performed best at reducing reactive oxygen species.
The rationale rests on a familiar problem in neurodegeneration. Reactive oxygen species, including hydrogen peroxide, are normal byproducts of metabolism and serve useful purposes at low levels, but when they accumulate they can trigger cell death, damage proteins and cause mutations. The body's own defenses, such as catalase and other antioxidant enzymes, can be overwhelmed once that buildup takes hold, which is why researchers are interested in antioxidants that come in through food or supplements. Conditions including Alzheimer's and Parkinson's disease, along with anxiety and depression, are frequently accompanied by excess reactive oxygen species.
This is cell-culture research, not a trial in people, and it shows that a specific egg yolk peptide preparation can blunt oxidative stress in a dish rather than that eating eggs affects brain aging. Its practical value for now is in pointing food scientists toward which processing and hydrolysis methods yield the most active peptides, a necessary step before anyone can test whether such ingredients do anything useful in the human brain.